A Significant Adverse Correlation between Serum Cortisol and TSH in a Case of Cyclic Cushing's Disease Based on a Continuous Three-year Observation

The suppressive effects of exogeneous glucocorticoid on the hypothalamo-pituitary-thyroid axis is a well-known fact [1-3]. There have also been many studies of healthy volunteers [1], patients with Cushing's syndrome [4] and patients with congenital adrenal hyperplasia [5], regarding the role o...

Full description

Saved in:
Bibliographic Details
Published inENDOCRINE JOURNAL Vol. 50; no. 6; pp. 833 - 834
Main Authors Yamaguchi, Kohei, Hashiguchi, Yasuhiro
Format Journal Article
LanguageEnglish
Published Japan The Japan Endocrine Society 2003
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The suppressive effects of exogeneous glucocorticoid on the hypothalamo-pituitary-thyroid axis is a well-known fact [1-3]. There have also been many studies of healthy volunteers [1], patients with Cushing's syndrome [4] and patients with congenital adrenal hyperplasia [5], regarding the role of endogenous glucocorticoid in the regulation of TSH. However, there have been no reports on the relationship of serum cortisol and TSH in cyclic Cushing's syndrome. A 71-year-old woman with clinical signs of Gushing's disease was observed continuously for three years during which serum cortisol levels fluctuated from 10 to 57 μg/dl and serum TSH levels ranged 0.05 to 3.15 μIU/ml. As can be seen in the main Fig.1, cortisol levels peaked twice during the first two years. Beginning in May 1997 the patient began receiving 120-180 mg/day of trilostane, and seemed to respond. However, in July 1998, her serum cortisol levels began to rise to about 20 μg/dl (this period is not shown in the main Fig.1). The patient demonstrated two important features of cyclic Gushing's disease:absence of ACTH response to CRH administration and non-suppressibility in response to high dose dexamethasone other than the cyclicity of ACTH and cortisol.
ISSN:0918-8959
1348-4540
DOI:10.1507/endocrj.50.833